M R Litzow

Learn More
We designed a phase I clinical trial of escalating doses of topotecan with cyclophosphamide and carboplatin in combination with autologous hematopoietic stem cell transplantation (AHSCT) for the treatment of relapsed or persistent platinum sensitive ovarian or primary peritoneal carcinoma. After stem cell collection, sixteen patients received topotecan at(More)
Peripheral Blood Stem Cells (PBSC) are usually mobilized using granulocyte colony stimulating factor (G-CSF) with or without chemotherapy. With the emergence of newer mobilizing agents, predicting poor mobilization may allow early intervention and prevent the costs and complications associated with remobilization. We retrospectively evaluated a cohort of(More)
  • 1